Eliapixant clinical trials

Studies by the year they started

14 studies that test it; most in 2020 (8)

Who runs them

Industry 14 · Other 0

Bayer (14)

Often tested with

Tested in the same studies.

Rosuvastatin (1)

Studies

Open first, then newest update. How each study uses eliapixant is read from its arms, and is right about nine times in ten.

Testing it · 14

• Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal FunctionCompletedPhase 1BayerNCT04471337Written as BAY1817080
• Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the WombTerminatedPhase 2BayerNCT04614246Written as BAY1817080
• A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)CompletedPhase 1BayerNCT04487431Written as BAY1817080
• Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male ParticipantsCompletedPhase 1BayerNCT04265781Written as BAY1817080
• Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough PatientsCompletedPhase 1/2BayerNCT03310645Written as BAY1817080
• Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver FunctionCompletedPhase 1BayerNCT04454424Written as BAY1817080
• Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)CompletedPhase 2BayerNCT04545580Written as BAY1817080
• A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic PainTerminatedPhase 2BayerNCT04641273Written as BAY1817080
• A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese MenCompletedPhase 1BayerNCT04802343Written as BAY1817080
• Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic CoughCompletedPhase 2BayerNCT04562155Written as BAY1817080
• Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female ParticipantsCompletedPhase 1BayerNCT04423744Written as BAY1817080
• Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult ParticipantsCompletedPhase 1BayerNCT04252300Written as Rosuvastatin + BAY1817080
• A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the VeinCompletedPhase 1BayerNCT03773068Written as BAY1817080 - Formulation A
• First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080CompletedPhase 1BayerNCT02817100Written as BAY1817080

Codes

What other systems call eliapixant · ClinicalTrials.gg INT015865

• UNII (FDA) 9GH7E6347BELIAPIXANTOne source FDA
• NCI Thesaurus C175513EliapixantOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.